Literature DB >> 29473494

Protein Tyrosine Nitration in Lung Cancer: Current Research Status and Future Perspectives.

Xianquan Zhan1,2,3,4, Yuda Huang1,2,3, Shehua Qian1,2,3.   

Abstract

Oxidative/nitrative damage is a crucial element among the complex factors that contribute to lung carcinogenesis. Nitric oxide (NO) free radicals, through chemical modifications such as tyrosine nitration, are significantly involved in lung carcinogenesis and metastasis. NO-mediated protein nitration, which is the addition of the nitro group (-NO2) to position 3 of the phenolic ring of a tyrosine residue, is an important molecular event in lung cancer, and has been studied with mass spectrometry. Nitration is involved in multiple biological processes, including signal transduction, protein degradation, energy metabolism, mitochondrial dysfunction, enzyme inactivation, immunogenic response, apoptosis, and cell death. This article reviews the relationship of NO and its derivates and lung cancer, formation and roles of tyrosine nitration in lung cancer, differences of protein nitration between lung cancer and other inflammatory pulmonary diseases, current status of protein nitration and nitroproteomics in lung cancer, and future perspectives to achieve a better understanding of lung carcinogenesis, for biomarker discovery; and for new diagnostic and prognostic monitoring, and therapeutic targets. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Lung cancer; mass spectrometry; nitroproteomics; structural biology; systems biology; tyrosine nitration.

Mesh:

Substances:

Year:  2018        PMID: 29473494     DOI: 10.2174/0929867325666180221140745

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  8 in total

1.  Nitric Oxide Mediated Degradation of CYP2A6 via the Ubiquitin-Proteasome Pathway in Human Hepatoma Cells.

Authors:  John Cerrone; Choon-Myung Lee; Tian Mi; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2020-04-29       Impact factor: 3.922

2.  Identification of pathology-specific regulators of m6A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicine.

Authors:  Na Li; Xianquan Zhan
Journal:  EPMA J       Date:  2020-07-29       Impact factor: 6.543

3.  A pilot study on nitration/dysfunction of NK1 segment of myogenic stem cell activator HGF.

Authors:  Alaa Elgaabari; Nana Imatomi; Hirochika Kido; Miyumi Seki; Sakiho Tanaka; Yuji Matsuyoshi; Takashi Nakashima; Shoko Sawano; Wataru Mizunoya; Takahiro Suzuki; Mako Nakamura; Judy E Anderson; Ryuichi Tatsumi
Journal:  Biochem Biophys Rep       Date:  2022-06-11

4.  Antioxidant-Conjugated Peptide Attenuated Metabolic Reprogramming in Pulmonary Hypertension.

Authors:  Mathews Valuparampil Varghese; Maki Niihori; Cody A Eccles; Sergey Kurdyukov; Joel James; Olga Rafikova; Ruslan Rafikov
Journal:  Antioxidants (Basel)       Date:  2020-01-25

5.  Nitric oxide in occurrence, progress and therapy of lung Cancer: a systemic review and meta-analysis.

Authors:  Hongbin Zhou; Jiuke Li; Zhewen Chen; Ying Chen; Sa Ye
Journal:  BMC Cancer       Date:  2021-06-08       Impact factor: 4.430

Review 6.  Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis.

Authors:  Vladimir I Muronetz; Maria V Medvedeva; Irina A Sevostyanova; Elena V Schmalhausen
Journal:  Biomolecules       Date:  2021-11-08

Review 7.  Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.

Authors:  Yuna Guo; Wenshuang Jia; Jingru Yang; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055

Review 8.  Targeting cytoskeletal phosphorylation in cancer.

Authors:  Clara Llorente-González; Marta González-Rodríguez; Miguel Vicente-Manzanares
Journal:  Explor Target Antitumor Ther       Date:  2021-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.